Table 2.
Adherence and efficacy data for autologous and allogeneic patients. Values are reported as medians.
| Autologous Cohort | Allogeneic Cohort | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Pre | Change | p-value | Pre | Change | p-value | |
|
|
|
|||||
| VO2peak (ml/kg*min) | 16.1 | +1.1 | 0.12 | 18.1 | +3.7 | 0.005 |
|
| ||||||
| VO2peak (L/min) | 1.23 | +0.15 | 0.09 | 1.33 | +0.31 | 0.004 |
|
| ||||||
| 6MWD (m) | 525 | +30 | 0.19 | 495 | +34 | 0.006 |
|
| ||||||
| RER (pre-post) | 1.15-1.19 | 1.23-1.27 | ||||
|
| ||||||
| Number of weeks participated |
4.0 | 5.0 | ||||
|
| ||||||
| Number of IET sessions participated |
7.0 | 11.0 | ||||
|
| ||||||
| Median duration of IET sessions (minutes) |
30 | 30 | ||||
|
| ||||||
| Maximum HR achieved (bpm, % MHR) |
159, 91% | 161, 89% | ||||
|
| ||||||
| Daily Steps | 5547 | 5178 | ||||